BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 27834668)

  • 21. Fibroblast Growth Factors and Vascular Endothelial Growth Factor Promote Cardiac Reprogramming under Defined Conditions.
    Yamakawa H; Muraoka N; Miyamoto K; Sadahiro T; Isomi M; Haginiwa S; Kojima H; Umei T; Akiyama M; Kuishi Y; Kurokawa J; Furukawa T; Fukuda K; Ieda M
    Stem Cell Reports; 2015 Dec; 5(6):1128-1142. PubMed ID: 26626177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitro.
    Qian L; Berry EC; Fu JD; Ieda M; Srivastava D
    Nat Protoc; 2013 Jun; 8(6):1204-15. PubMed ID: 23722259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization and enrichment of induced cardiomyocytes derived from mouse fibroblasts by reprogramming with cardiac transcription factors.
    Tian J; Wang R; Hou Q; Li M; Chen L; Deng X; Zhu Z; Zhao Y; He W; Fu X
    Mol Med Rep; 2018 Mar; 17(3):3912-3920. PubMed ID: 29257325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming.
    Christoforou N; Chellappan M; Adler AF; Kirkton RD; Wu T; Addis RC; Bursac N; Leong KW
    PLoS One; 2013; 8(5):e63577. PubMed ID: 23704920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-enhanced mRNA transfection in cultured mouse cardiac fibroblasts and direct reprogramming towards cardiomyocyte-like cells.
    Lee K; Yu P; Lingampalli N; Kim HJ; Tang R; Murthy N
    Int J Nanomedicine; 2015; 10():1841-54. PubMed ID: 25834424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming.
    Muraoka N; Nara K; Tamura F; Kojima H; Yamakawa H; Sadahiro T; Miyamoto K; Isomi M; Haginiwa S; Tani H; Kurotsu S; Osakabe R; Torii S; Shimizu S; Okano H; Sugimoto Y; Fukuda K; Ieda M
    Nat Commun; 2019 Feb; 10(1):674. PubMed ID: 30787297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5.
    Chen JX; Krane M; Deutsch MA; Wang L; Rav-Acha M; Gregoire S; Engels MC; Rajarajan K; Karra R; Abel ED; Wu JC; Milan D; Wu SM
    Circ Res; 2012 Jun; 111(1):50-5. PubMed ID: 22581928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac reprogramming factor Gata4 reduces postinfarct cardiac fibrosis through direct repression of the profibrotic mediator snail.
    Mathison M; Singh VP; Sanagasetti D; Yang L; Pinnamaneni JP; Yang J; Rosengart TK
    J Thorac Cardiovasc Surg; 2017 Nov; 154(5):1601-1610.e3. PubMed ID: 28711329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor.
    Mathison M; Gersch RP; Nasser A; Lilo S; Korman M; Fourman M; Hackett N; Shroyer K; Yang J; Ma Y; Crystal RG; Rosengart TK
    J Am Heart Assoc; 2012 Dec; 1(6):e005652. PubMed ID: 23316332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct In Vivo Reprogramming with Sendai Virus Vectors Improves Cardiac Function after Myocardial Infarction.
    Miyamoto K; Akiyama M; Tamura F; Isomi M; Yamakawa H; Sadahiro T; Muraoka N; Kojima H; Haginiwa S; Kurotsu S; Tani H; Wang L; Qian L; Inoue M; Ide Y; Kurokawa J; Yamamoto T; Seki T; Aeba R; Yamagishi H; Fukuda K; Ieda M
    Cell Stem Cell; 2018 Jan; 22(1):91-103.e5. PubMed ID: 29276141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin C facilitates direct cardiac reprogramming by inhibiting reactive oxygen species.
    Fang J; Yang Q; Maas RGC; Buono M; Meijlink B; Lotgerink Bruinenberg D; Benavente ED; Mokry M; van Mil A; Qian L; Goumans MJ; Schiffelers R; Lei Z; Sluijter JPG
    Stem Cell Res Ther; 2024 Jan; 15(1):19. PubMed ID: 38229180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Context-Specific Transcription Factor Functions Regulate Epigenomic and Transcriptional Dynamics during Cardiac Reprogramming.
    Stone NR; Gifford CA; Thomas R; Pratt KJB; Samse-Knapp K; Mohamed TMA; Radzinsky EM; Schricker A; Ye L; Yu P; van Bemmel JG; Ivey KN; Pollard KS; Srivastava D
    Cell Stem Cell; 2019 Jul; 25(1):87-102.e9. PubMed ID: 31271750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming.
    Wang L; Liu Z; Yin C; Asfour H; Chen O; Li Y; Bursac N; Liu J; Qian L
    Circ Res; 2015 Jan; 116(2):237-44. PubMed ID: 25416133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p63 silencing induces epigenetic modulation to enhance human cardiac fibroblast to cardiomyocyte-like differentiation.
    Pinnamaneni JP; Singh VP; Kim MB; Ryan CT; Pugazenthi A; Sanagasetti D; Mathison M; Yang J; Rosengart TK
    Sci Rep; 2022 Jul; 12(1):11416. PubMed ID: 35794145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Directed Differentiation of Embryonic Stem Cells Into Cardiomyocytes by Bacterial Injection of Defined Transcription Factors.
    Bai F; Ho Lim C; Jia J; Santostefano K; Simmons C; Kasahara H; Wu W; Terada N; Jin S
    Sci Rep; 2015 Oct; 5():15014. PubMed ID: 26449528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Triplet" polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors.
    Mathison M; Singh VP; Gersch RP; Ramirez MO; Cooney A; Kaminsky SM; Chiuchiolo MJ; Nasser A; Yang J; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1656-1664.e2. PubMed ID: 24755332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Future of Direct Cardiac Reprogramming: Any
    López-Muneta L; Miranda-Arrubla J; Carvajal-Vergara X
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells.
    Protze S; Khattak S; Poulet C; Lindemann D; Tanaka EM; Ravens U
    J Mol Cell Cardiol; 2012 Sep; 53(3):323-32. PubMed ID: 22575762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures.
    Muraoka N; Yamakawa H; Miyamoto K; Sadahiro T; Umei T; Isomi M; Nakashima H; Akiyama M; Wada R; Inagawa K; Nishiyama T; Kaneda R; Fukuda T; Takeda S; Tohyama S; Hashimoto H; Kawamura Y; Goshima N; Aeba R; Yamagishi H; Fukuda K; Ieda M
    EMBO J; 2014 Jul; 33(14):1565-81. PubMed ID: 24920580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac gene activation analysis in mammalian non-myoblasic cells by Nkx2-5, Tbx5, Gata4 and Myocd.
    Zhou L; Liu Y; Lu L; Lu X; Dixon RA
    PLoS One; 2012; 7(10):e48028. PubMed ID: 23144723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.